UK drug regulator approves Alzheimer’s drug but government likely won’t pay for it
LONDON — Britain’s drug regulator authorized the Alzheimer’s drug Leqembi on Thursday, saying it’s the first medicine to show some impact in slowing the progression of the neurodegenerative disease. But…